Carl Allenspach is a distinguished professional with 27 years of expertise in pharmaceutical development and manufacturing. He currently leads the Business Operations group and serves as Chief of Staff for the Manufacturing Science and Technology organization at Bristol Myers Squibb, overseeing both small molecules and biologics. Throughout his career at Pfizer, Novartis, and BMS, Carl has significantly contributed to the development, clinical supply, tech transfer, commercial manufacturing, and global filings of over 45 compounds. An active member of AAPS since 2004, he has chaired multiple committees and is presently the Past Chair for Interphex, as well as a leader in the Manufacturing Science and Engineering Community. Carl holds a Ph.D. in Pharmaceutical Science from Rutgers University and a B.S. in Chemistry from Roosevelt University.